Feasibility and acceptability of using medical and nursing students to provide Implanon NXT at the community level in Kinshasa, Democratic Republic of Congo

Springer Science and Business Media LLC - Tập 20 - Trang 1-13 - 2020
Julie H. Hernandez1, Pierre Akilimali2, Annie Glover1, Jane T. Bertrand1
1Department of Health Policy and Management, Tulane University School of Public Health and Tropical Medicine, New Orleans, USA
2Kinshasa School of Public Health, University of Kinshasa, Kinshasa, Democratic Republic of the Congo

Tóm tắt

The use of implants has steadily increased in Kinshasa since 2013 but clinic-based access to this family planning method is limited due to distance and costs barriers. The objective of this study was to examine the feasibility and acceptability of providing Implanon NXT at the community level using medical and nursing students (M/N) as distributors, as part of a strategy to improve contraceptive uptake in the Democratic Republic of Congo. A cohort of 531 women who chose to receive Implanon NXT from a M/N student during community-based campaign days participated in three rounds of a quantitative survey administered at the time of insertion of the method, and at 6 and 12 months later. We conducted descriptive analysis to assess the feasibility and acceptability of providing the method through M/N students in terms of method choice, user profiles, contraceptive history, experience with insertion and side effects, continuation / discontinuation of the method, and overall satisfaction with FP services as well as students’ preparedness and capacity to safely offer the method, and their satisfaction with the experience.. The study demonstrated the feasibility of training students for community-based provision of Implanon NXT and 95% of them were satisfied with their experience. Acceptability of both the method and the service delivery strategy was high among participants, including among young and first-time contraceptive users. Out of the 441 women with a known outcome at 12 months, 92% still had Implanon NXT inserted, despite some of them reporting experiencing side effects. The vast majority (79%) would “strongly recommend” obtaining NXT from a M/N student if a friend wanted to avoid pregnancies. The provision of Implanon NXT at the community-level is a promising solution to address some of the barriers to accessing this method for women living in Kinshasa. However, strengthening pre-insertion counseling, particularly on expected side-effects and the possibility of early removal, is necessary to increase informed choice for the women and potentially limit method discontinuation.

Tài liệu tham khảo

Polus S, Lewin S, Glenton C, Lerberg PM, Rehfuess E, Gülmezoglu AM. Optimizing the delivery of contraceptives in low-and middle-income countries through task shifting: a systematic review of effectiveness and safety. Reprod Health. 2015;12(1):27. Dawson AJ, Buchan J, Duffield C, Homer CS, Wijewardena K. Task shifting and sharing in maternal and reproductive health in low-income countries: a narrative synthesis of current evidence. Health Policy Plan. 2014;29(3):396–408. Stanback J, Mbonye AK, Bekiita M. Contraceptive injections by community health workers in Uganda: a nonrandomized community trial. Bull World Health Organ. 2007;85:768–73. Hoke TH, Wheeler SB, Lynd K, Green MS, Razafindravony BH, Rasamihajamanana E, Blumenthal PD. Community-based provision of injectable contraceptives in Madagascar:‘task shifting’to expand access to injectable contraceptives. Health Policy Plan. 2012;27(1):52–9. Hoke T, Brunie A, Krueger K, Dreisbach C, Akol A, Rabenja NL, et al. Community-based distribution of injectable contraceptives: introduction strategies in four sub-Saharan African countries. Int Perspect Sex Reprod Health. 2012;38(4):214–9. Cover J, Ba M, Lim J, Drake JK, Daff BM. Evaluating the feasibility and acceptability of self-injection of subcutaneous depot medroxyprogesterone acetate (DMPA) in Senegal: a prospective cohort study. Contraception. 2017;96(3):203–10. Burke HM, Mueller MP, Perry B, Packer C, Bufumbo L, Mbengue D, et al. Observational study of the acceptability of Sayana® press among intramuscular DMPA users in Uganda and Senegal. Contraception. 2014;89(5):361–7. PMA2015/DRC-Round 6: Key family planning indicator brief. Performance monitoring and accountability 2020 (PMA2020) Project [Internet]. 2017. Available from: https://www.pma2020.org/sites/default/files/EN-DRC-KongoCentral-R3-FP-Brief_2.pdf. Ministère de la Santé Publique (MSP). Planification Familiale: Plan Stratégique National à Vision Multisectorielle (2014–2020). Kinshasa: MSP; 2014. http://www.observaction.info/wp-content/uploads/2016/06/Final-Plan-Strategique-version-officielle.pdf. Last accessed: 27 Apr 2020. Bertrand JT, Makani PB, Hernandez J, Akilimali P, Mukengeshayi B, Babazadeh S, Binanga A. Acceptability of the community-level provision of Sayana® press by medical and nursing students in Kinshasa, Democratic Republic of the Congo. Contraception. 2017;96(3):211–5. Binanga A, Bertrand JT. Pilot research as advocacy: the case of Sayana Press in Kinshasa, Democratic Republic of the Congo. Glob Health Sci Pract. 2016;4(4):542–51. Rowlands S, Searle S. Contraceptive implants: current perspectives. Open Access J Contracept. 2014;5:73–84. Duvall S, Thurston S, Weinberger M, Nuccio O, Fuchs-Montgomery N. Scaling up delivery of contraceptive implants in sub-Saharan Africa: operational experiences of Marie Stopes international. Glob Health Sci Pract. 2014;2(1):72–92. Charyeva Z, Oguntunde O, Orobaton N, Otolorin E, Inuwa F, Alalade O, Abegunde D. Task shifting provision of contraceptive implants to community health extension workers: results of operations research in northern Nigeria. Glob Health Sci Pract. 2015;3(3):382–94. Asnake M, Henry EG, Tilahun Y, Oliveras E. Addressing unmet need for long-acting family planning in Ethiopia: uptake of single-rod progestogen contraceptive implants (Implanon) and characteristics of users. Int J Gynecol Obstet. 2013;123:e29–32. Hindin MJ, McGough LJ, Adanu RM. Misperceptions, misinformation and myths about modern contraceptive use in Ghana. J Fam Plann Reprod Health Care. 2014;40(1):30–5. Hoggart L, Newton VL. Young women’s experiences of side-effects from contraceptive implants: a challenge to bodily control. Reprod Health Matters. 2013;21(41):196–204. Polis B, Hussein R, Berry A. There might be blood: a scoping review on women's responses to contraceptive-induced menstrual bleeding changes. Reprod Health J. 2018;15(1):1. Pillay D, Chersich MF, Morroni C, Pleaner M, Adeagbo OA, Naidoo N, Mullick S, Rees H. User perspectives on Implanon NXT in South Africa: a survey of 12 public-sector facilities. S Afr Med J. 2017;107(10):815–21. O’Neil ME, Peipert JF, Zhao Q, Madden T, Secura G. Twenty-four–month continuation of reversible contraception. Obstet Gynecol. 2013;122(5):1083. Short M, Dallay D, Omokanye S, Stauch K, Inki P. Acceptability of long-acting, progestin-only contraception in Europe: a two-year prospective, non-interventional study. Eur J Contracept Reprod Health Care. 2014;19(1):29–38. Weisberg E, Bateson D, McGeechan K, Mohapatra L. A three-year comparative study of continuation rates, bleeding patterns and satisfaction in Australian women using a subdermal contraceptive implant or progestogen releasing-intrauterine system. Eur J Contracept Reprod Health Care. 2014;19(1):5–14. Bertrand JT, Bidashimwa D, Makani PB, Hernandez JH, Akilimali P, Binanga A. An observational study to test the acceptability and feasibility of using medical and nursing students to instruct clients in DMPA-SC self-injection at the community level in Kinshasa. Contraception. 2018;98(5):411–7. Kwete D, Binanga A, Mukaba T, Nemuandjare T, Mbadu MF, Kyungu MT, Bertrand JT. Family planning in the Democratic Republic of the Congo: encouraging momentum, formidable challenges. Glob Health Sci Pract. 2018;6(1):40–54. Muanda M, Ndongo PG, Taub LD, Bertrand JT. Barriers to modern contraceptive use in Kinshasa, DRC. PLoS One. 2016;11(12):e0167560. Flore M, Chen X, Bonney A, Mullan J, Dijkmans-Hadley B, Hodgkins A, Evans G, Frew H, Lloyd G. Patients’ perspectives about why they have their contraceptive Implanon NXT device removed early. Aust Fam Physician. 2016;45(10):740.